USD 1.6
(6.67%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 16.78 Million USD | -43.82% |
2022 | 29.87 Million USD | 134.44% |
2021 | 12.74 Million USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 16.33 Million USD | 0.0% |
2024 Q2 | 15.87 Million USD | 0.0% |
2023 Q2 | 17.64 Million USD | 50.21% |
2023 Q3 | 17.22 Million USD | -2.41% |
2023 Q1 | 11.74 Million USD | -60.68% |
2023 FY | 16.78 Million USD | -43.82% |
2023 Q4 | 16.78 Million USD | -2.53% |
2022 Q3 | 30.33 Million USD | -1.42% |
2022 FY | 29.87 Million USD | 134.44% |
2022 Q4 | 29.87 Million USD | -1.49% |
2022 Q2 | 30.76 Million USD | 145.63% |
2022 Q1 | 12.52 Million USD | -1.72% |
2021 Q1 | - USD | -100.0% |
2021 Q3 | 12.96 Million USD | -1.63% |
2021 Q4 | 12.74 Million USD | -1.67% |
2021 FY | 12.74 Million USD | 0.0% |
2021 Q2 | 13.17 Million USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | 693 Thousand USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acutus Medical, Inc. | 32.65 Million USD | 48.594% |
Biotricity, Inc. | 10.85 Million USD | -54.627% |
Cell MedX Corp. | - USD | -Infinity% |
Dynatronics Corporation | 3.25 Million USD | -415.148% |
Nemaura Medical Inc. | 3.08 Million USD | -443.65% |
PetVivo Holdings, Inc. | 1.01 Million USD | -1550.654% |
RetinalGenix Technologies Inc. | - USD | -Infinity% |
Sonendo, Inc. | 14.03 Million USD | -19.601% |
Telesis Bio, Inc. | 5.26 Million USD | -218.58% |
Viveve Medical, Inc. | 5.12 Million USD | -227.596% |